<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ketamine was administered to 18 baboons (Papio papio) to disrupt <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> discharges elicited through intracarotid air injection </plain></SENT>
<SENT sid="1" pm="."><plain>Discharge suppression was obtained in <z:hpo ids='HP_0000001'>all</z:hpo> animals but could be preceded by a phase of enhancement of the <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> patterns, which rendered necessary the injection of a supplementary dose </plain></SENT>
<SENT sid="2" pm="."><plain>The mechanisms of Ketamine action are discussed, in connection with data from the literature </plain></SENT>
<SENT sid="3" pm="."><plain>Some of the latter suggest that its use in proved <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptics</z:e> facilitates paroxystic patterns or even <z:mp ids='MP_0000947'>convulsions</z:mp> while others emphasize its <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> action </plain></SENT>
<SENT sid="4" pm="."><plain>Present data corroborate the ambivalent action of this drug </plain></SENT>
<SENT sid="5" pm="."><plain>However, its dominant depressant effect obtained with increasing doses is somewhat favourable to its administration to <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> patients </plain></SENT>
</text></document>